IoT leader delivers solid results with record
revenue in Industrial & Commercial
AUSTIN,
Texas, July 26, 2023 /PRNewswire/ -- Silicon
Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless
technology for a more connected world, reported financial results
for the second quarter, which ended July 1,
2023. Revenue exceeded the mid-point of the guidance range
at $245 million, driven by strength
across the Industrial & Commercial end markets.
"We delivered solid results in the second quarter, with record
revenue in our Industrial & Commercial business," said
Matt Johnson, President and Chief
Executive Officer at Silicon Labs. "The strength in Industrial
& Commercial was offset by a decline in our Home & Life
business as weak demand and excess customer inventory continue to
impact our results. Despite the challenging near-term outlook, we
continue to drive strong design win momentum with our leading
platform, products, and broad customer base. As the market
stabilizes, we are well-positioned to gain share and drive
long-term revenue growth."
Second Quarter Financial Highlights
- Revenue was $245 million, in-line
with guidance
- Industrial & Commercial revenue for the quarter was
$165 million
- Home & Life revenue for the quarter was $80 million
Results on a GAAP
basis:
- GAAP gross margin was 58.7%
- GAAP R&D expenses were $86
million
- GAAP SG&A expenses were $41
million
- GAAP operating income as a percentage of revenue was 7%
- GAAP diluted earnings per share were $0.33
Results on a non-GAAP basis, excluding the impact of stock
compensation, amortization of acquired intangible assets, and
certain other items as set forth in the below GAAP to Non-GAAP
reconciliation tables were as follows:
- Non-GAAP gross margin was 58.9%
- Non-GAAP R&D expenses were $70
million
- Non-GAAP SG&A expenses were $35
million
- Non-GAAP operating income as a percentage of revenue was
16%
- Non-GAAP diluted earnings per share were $1.04
Business Highlights
- Announced the new dual-band FG28 SoC, designed for long-range
networks and protocols like Amazon Sidewalk, Wi-SUN, and other
proprietary protocols. The FG28 includes radios for sub-Gigahertz
(Ghz) and 2.4 Ghz Bluetooth LE, making it particularly attractive
for edge applications in growth areas like smart agriculture, smart
cities, and neighborhood networks. The built-in AI/ML accelerator
is a first for a sub-Ghz SoC, bringing AI/ML to the edge.
- Opened registration for its fourth annual Works With
Conference, which attracts over 8,000 IoT developers every year.
The free virtual conference will be held on August 22nd and 23rd and will feature over 40
in-depth technical sessions covering every major IoT protocol and
ecosystem. Taught by Silicon Labs engineers and other industry
experts, the sessions are designed to demystify, simplify, and
accelerate the development of IoT products. CEO Matt Johnson will share a sneak peek of Silicon
Labs' next-generation Series 3 platform in the conference's opening
keynote.
- Finalized the redemption process on its 2025 convertible notes.
The company funded the $535 million
par value of the notes in cash. The in-the-money component of the
converted notes was settled with the issuance of approximately 0.9
million shares. The company also executed approximately
$184 million in additional stock
repurchases in the quarter, retiring approximately 1.3 million
shares. On July 20th, the company's
board of directors authorized an incremental $100 million to its existing authorization for
the repurchase of the company's common stock, bringing the total
remaining amount authorized through the end of 2023 to
approximately $116 million.
- Held the grand opening of the Silicon Labs Connectivity Lab in
our Boston site, an event attended
by top customers and partners. The Connectivity Lab simulates a
modern Smart Home, with a range of IoT devices, applications,
ecosystems, and networks. It offers developers an ideal environment
to test their Matter prototypes operating within real-world
scenarios across a variety of protocols and device brands.
Business Outlook
The company expects third-quarter revenue to be between
$190 to $210
million. The company also estimates the following
results:
On a GAAP basis:
- GAAP gross margin to be 59%
- GAAP operating expenses of approximately $120 million
- GAAP diluted earnings (loss) per share between $(0.08) to $0.20
On a non-GAAP basis, excluding the impact of stock compensation,
amortization of acquired intangible assets, and certain other items
as set forth in the reconciliation tables:
- Non-GAAP gross margin to be 59%
- Non-GAAP operating expenses of approximately $95 million
- Non-GAAP diluted earnings per share between $0.45 to $0.73
Earnings Webcast and Conference Call
Silicon Labs will host an earnings conference call to discuss
the quarterly results and answer questions at 7:30 am CDT today. An audio webcast will be
available on Silicon Labs' website (www.silabs.com) under Investor
Relations. In addition, the company will post an audio recording of
the event at silabs.com/investors and make a replay available
through August 26, 2023, online or by
calling (877) 344-7529 (US) or (412) 317-0088 (international) and
entering access code 1518188.
About Silicon Labs
Silicon Labs (NASDAQ: SLAB) is a leader in secure,
intelligent wireless technology for a more connected
world. Our integrated hardware and software platform,
intuitive development tools, thriving ecosystem, and
robust support make us an ideal long-term partner in building
advanced industrial, commercial, home and life
applications. We make it easy for developers to solve
complex wireless challenges throughout the
product lifecycle and get to market
quickly with innovative solutions that transform
industries, grow economies, and improve lives.
silabs.com
Forward-Looking Statements
This press release contains forward-looking statements based on
Silicon Labs' current expectations. The words "believe",
"estimate", "expect", "intend", "anticipate", "plan", "project",
"will", and similar phrases as they relate to Silicon Labs are
intended to identify such forward-looking statements. These
forward-looking statements reflect the current views and
assumptions of Silicon Labs and are subject to various risks and
uncertainties that could cause actual results to differ materially
from expectations. Among the factors that could cause actual
results to differ materially from those in the forward-looking
statements are the following: the competitive and cyclical nature
of the semiconductor industry; the challenging macroeconomic
environment, including disruptions in the financial services
industry; geographic concentration of manufacturers, assemblers,
test service providers and customers in Asia that subjects Silicon Labs' business and
results of operations to risks of natural disasters, epidemics or
pandemics, war and political unrest; risks that demand and the
supply chain may be adversely affected by military conflict
(including between Russia and
Ukraine), terrorism, sanctions or
other geopolitical events globally (including conflict between
Taiwan and China); risks that Silicon Labs may not be
able to maintain its historical growth; quarterly fluctuations in
revenues and operating results; difficulties developing new
products that achieve market acceptance; risks associated with
international activities (including trade barriers, particularly
with respect to China);
intellectual property litigation risks; risks associated with
acquisitions and divestitures; product liability risks;
difficulties managing and/or obtaining sufficient supply from
Silicon Labs' distributors, manufacturers and subcontractors;
dependence on a limited number of products; absence of long-term
commitments from customers; inventory-related risks; difficulties
managing international activities; risks that Silicon Labs may not
be able to manage strains associated with its growth; credit risks
associated with its accounts receivable; dependence on key
personnel; stock price volatility; the impact of COVID-19 on the
U.S. and global economy; debt-related risks; capital-raising risks;
the timing and scope of share repurchases and/or dividends; average
selling prices of products may decrease significantly and rapidly;
information technology risks; cyber-attacks against Silicon Labs'
products and its networks and other factors that are detailed in
the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims
any intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events,
or otherwise. References in this press release to Silicon Labs
shall mean Silicon Laboratories Inc.
Note to editors: Silicon Laboratories, Silicon Labs, the "S"
symbol, and the Silicon Labs logo are trademarks of Silicon
Laboratories Inc. All other product names noted herein may be
trademarks of their respective holders.
Silicon Laboratories
Inc.
Condensed
Consolidated Statements of Income
(In thousands,
except per share data)
(Unaudited)
|
|
|
Three Months
Ended
|
|
Six Months
Ended
|
|
July 1,
2023
|
|
July 2,
2022
|
|
July 1,
2023
|
|
July 2,
2022
|
Revenues
|
$244,866
|
|
$263,150
|
|
$491,653
|
|
$496,964
|
Cost of
revenues
|
101,091
|
|
99,247
|
|
194,018
|
|
177,289
|
Gross profit
|
143,775
|
|
163,903
|
|
297,635
|
|
319,675
|
Operating
expenses:
|
|
|
|
|
|
|
|
Research
and development
|
85,902
|
|
83,511
|
|
175,298
|
|
161,053
|
Selling,
general and administrative
|
40,706
|
|
49,013
|
|
85,597
|
|
93,660
|
Operating
expenses
|
126,608
|
|
132,524
|
|
260,895
|
|
254,713
|
Operating
income
|
17,167
|
|
31,379
|
|
36,740
|
|
64,962
|
Other income
(expense):
|
|
|
|
|
|
|
|
Interest
income and other, net
|
7,780
|
|
3,445
|
|
12,616
|
|
4,944
|
Interest
expense
|
(1,596)
|
|
(1,667)
|
|
(3,252)
|
|
(3,347)
|
Income before income
taxes
|
23,351
|
|
33,157
|
|
46,104
|
|
66,559
|
Provision for income
taxes
|
12,338
|
|
10,994
|
|
20,091
|
|
22,683
|
Equity-method earnings
(loss)
|
(57)
|
|
(28)
|
|
(1,090)
|
|
1,166
|
Net income
|
$
10,956
|
|
$
22,135
|
|
$
24,923
|
|
$
45,042
|
|
|
|
|
|
|
|
|
Earnings per
share:
|
|
|
|
|
|
|
|
Basic
|
$ 0.35
|
|
$ 0.62
|
|
$ 0.78
|
|
$ 1.22
|
Diluted
|
$ 0.33
|
|
$ 0.60
|
|
$ 0.75
|
|
$ 1.18
|
|
|
|
|
|
|
|
|
Weighted-average common
shares outstanding:
|
|
|
|
|
|
|
|
Basic
|
31,614
|
|
35,722
|
|
31,786
|
|
36,862
|
Diluted
|
32,926
|
|
36,604
|
|
33,339
|
|
38,063
|
Non-GAAP Financial Measurements
In addition to the GAAP results provided throughout this
document, Silicon Labs has provided non-GAAP financial measurements
on a basis excluding non-cash and other charges and benefits.
Details of these excluded items are presented in the tables below,
which reconcile the GAAP results to non-GAAP financial
measurements.
The non-GAAP financial measurements do not replace the
presentation of Silicon Labs' GAAP financial results. These
measurements provide supplemental information to assist management
and investors in analyzing Silicon Labs' financial position and
results of operations. Silicon Labs has chosen to provide this
information to investors to enable them to perform meaningful
comparisons of past, present and future operating results and as a
means to emphasize the results of core on-going operations.
Unaudited
Reconciliation of GAAP to Non-GAAP Financial
Measures
(In thousands,
except per share data)
|
|
|
|
Three Months
Ended
July 1,
2023
|
Non-GAAP Income
Statement Items
|
|
GAAP
Measure
|
|
GAAP
Percent of
Revenue
|
|
Stock
Compensation
Expense
|
|
Intangible
Asset
Amortization
|
|
Termination
Costs
|
|
Non-GAAP
Measure
|
|
Non-GAAP
Percent of
Revenue
|
Revenues
|
|
$244,866
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit
|
|
143,775
|
|
58.7 %
|
|
$283
|
|
$
--
|
|
$58
|
|
$144,116
|
|
58.9 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and
development
|
|
85,902
|
|
35.1 %
|
|
8,813
|
|
6,375
|
|
1,157
|
|
69,557
|
|
28.4 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and
administrative
|
|
40,706
|
|
16.6 %
|
|
5,643
|
|
19
|
|
368
|
|
34,676
|
|
14.2 %
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating
income
|
|
17,167
|
|
7.0 %
|
|
14,739
|
|
6,394
|
|
1,583
|
|
39,883
|
|
16.3 %
|
Non-GAAP Earnings
Per Share
|
|
Three Months
Ended
July 1,
2023
|
|
GAAP
Measure
|
|
Stock
Compensation
Expense*
|
|
Intangible
Asset
Amortization*
|
|
Termination
Costs*
|
|
Equity-Method
Investment
Adjustments*
|
|
Income
Tax
Adjustments
|
|
Non-
GAAP
Measure
|
Net income
|
|
$10,956
|
|
$14,739
|
|
$6,394
|
|
$1,583
|
|
$57
|
|
$530
|
|
$34,259
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted shares
outstanding
|
|
32,926
|
|
|
|
|
|
|
|
|
|
|
|
32,926
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
|
$
0.33
|
|
|
|
|
|
|
|
|
|
|
|
$
1.04
|
|
* Represents pre-tax
amounts
|
Unaudited
Forward-Looking Statements Regarding Business Outlook
(In millions, except per share data)
|
|
Business
Outlook
|
|
Three Months
Ending
September 30,
2023
|
|
|
GAAP
Measure
|
|
Non-GAAP
Adjustments**
|
|
Non-GAAP
Measure
|
Gross margin
|
|
59 %
|
|
0 %
|
|
59 %
|
|
|
|
|
|
|
|
Operating
expenses
|
|
$120
|
|
$(25)
|
|
$95
|
|
|
|
|
|
|
|
Diluted earnings (loss)
per share - low
|
|
$(0.08)
|
|
$0.53
|
|
$0.45
|
|
|
|
|
|
|
|
Diluted earnings per
share - high
|
|
$0.20
|
|
$0.53
|
|
$0.73
|
** Non-GAAP adjustments
include the following estimates: stock compensation expense of
$18.7 million, intangible asset amortization of $6.3 million,
termination costs of $0.3 million, and the associated tax
impact from the aforementioned items.
|
Silicon Laboratories
Inc.
Condensed
Consolidated Balance Sheets
(In thousands,
except per share data)
(Unaudited)
|
|
|
July
1,
2023
|
|
December
31,
2022
|
Assets
|
|
|
|
Current
assets:
|
|
|
|
Cash and
cash equivalents
|
$
234,813
|
|
$
499,915
|
Short-term
investments
|
271,063
|
|
692,024
|
Accounts
receivable, net
|
98,256
|
|
71,437
|
Inventories
|
145,523
|
|
100,417
|
Prepaid
expenses and other current assets
|
71,322
|
|
97,570
|
Total current
assets
|
820,977
|
|
1,461,363
|
Property and equipment,
net
|
152,358
|
|
152,016
|
Goodwill
|
376,389
|
|
376,389
|
Other intangible
assets, net
|
72,003
|
|
84,907
|
Other assets,
net
|
97,072
|
|
94,753
|
Total assets
|
$1,518,799
|
|
$2,169,428
|
|
|
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
Current
liabilities:
|
|
|
|
Accounts
payable
|
$ 55,102
|
|
$ 89,860
|
Revolving
line of credit
|
80,000
|
|
--
|
Deferred
revenue and returns liability
|
11,105
|
|
6,780
|
Other
current liabilities
|
72,339
|
|
89,136
|
Total current
liabilities
|
218,546
|
|
185,776
|
Convertible debt,
net
|
--
|
|
529,573
|
Other non-current
liabilities
|
41,356
|
|
49,071
|
Total
liabilities
|
259,902
|
|
764,420
|
Commitments and
contingencies
|
|
|
|
Stockholders'
equity:
|
|
|
|
Preferred
stock – $0.0001 par value; 10,000
shares authorized; no
shares
issued
|
--
|
|
--
|
Common
stock – $0.0001 par value; 250,000
shares authorized;
31,861 and 31,994
shares issued and outstanding at
July 1, 2023 and
December 31, 2022, respectively
|
3
|
|
3
|
Retained
earnings
|
1,262,984
|
|
1,415,693
|
Accumulated other comprehensive loss
|
(4,090)
|
|
(10,688)
|
Total stockholders'
equity
|
1,258,897
|
|
1,405,008
|
Total liabilities and
stockholders' equity
|
$1,518,799
|
|
$2,169,428
|
Silicon
Laboratories Inc.
Condensed
Consolidated Statements of Cash Flows
(In
thousands)
(Unaudited)
|
|
|
Six Months
Ended
|
|
July
1,
2023
|
|
July
2,
2022
|
Operating
Activities
|
|
|
|
Net income
|
$ 24,923
|
|
$ 45,042
|
Adjustments to
reconcile net income to net cash provided by (used in)
operating
activities
of continuing operations:
|
|
|
|
Depreciation of property and equipment
|
12,441
|
|
10,561
|
Amortization of other intangible assets
|
12,904
|
|
19,194
|
Amortization of debt issuance costs
|
960
|
|
994
|
Loss on
extinguishment of convertible debt
|
--
|
|
3
|
Stock-based compensation
expense
|
31,377
|
|
27,264
|
Equity-method (earnings) loss
|
1,090
|
|
(1,166)
|
Deferred
income taxes
|
(6,403)
|
|
(9,344)
|
Changes in
operating assets and liabilities:
|
|
|
|
Accounts
receivable
|
(26,819)
|
|
26,207
|
Inventories
|
(45,064)
|
|
(24,714)
|
Prepaid expenses and
other assets
|
32,963
|
|
(25,286)
|
Accounts
payable
|
(30,003)
|
|
25,606
|
Other current
liabilities and income taxes
|
(26,220)
|
|
(3,418)
|
Deferred revenue and
returns liability
|
4,326
|
|
(3,153)
|
Other non-current
liabilities
|
(1,975)
|
|
(4,416)
|
Net cash provided by
(used in) operating activities of continuing operations
|
(15,500)
|
|
83,374
|
|
|
|
|
Investing
Activities
|
|
|
|
Purchases of marketable
securities
|
(81,427)
|
|
(554,267)
|
Sales of marketable
securities
|
339,555
|
|
27,404
|
Maturities of
marketable securities
|
171,691
|
|
511,296
|
Purchases of property
and equipment
|
(13,462)
|
|
(12,322)
|
Purchases of other
assets
|
(215)
|
|
--
|
Net cash provided by
(used in) investing activities of continuing operations
|
416,142
|
|
(27,889)
|
|
|
|
|
Financing
Activities
|
|
|
|
Proceeds from revolving
line of credit
|
80,000
|
|
--
|
Payments on
debt
|
(536,124)
|
|
(21)
|
Repurchases of common
stock
|
(201,095)
|
|
(579,040)
|
Payment of taxes
withheld for vested stock awards
|
(16,310)
|
|
(13,958)
|
Proceeds from the
issuance of common stock
|
7,785
|
|
6,365
|
Net cash used in
financing activities of continuing operations
|
(665,744)
|
|
(586,654)
|
|
|
|
|
Discontinued
Operations
|
|
|
|
Operating
activities
|
--
|
|
(38,604)
|
Net cash used in
discontinued operations
|
--
|
|
(38,604)
|
|
|
|
|
Decrease in cash and
cash equivalents
|
(265,102)
|
|
(569,773)
|
Cash and cash
equivalents at beginning of period
|
499,915
|
|
1,074,623
|
Cash and cash
equivalents at end of period
|
$
234,813
|
|
$
504,850
|
View original content to download
multimedia:https://www.prnewswire.com/news-releases/silicon-labs-reports-second-quarter-2023-results-301885922.html
SOURCE Silicon Labs